Welcome, Guest
Username: Password: Remember me

TOPIC: Glecaprevir (NS3/4A) / Pibrentasvir (NS5A) equals Sof/Dac

Glecaprevir (NS3/4A) / Pibrentasvir (NS5A) equals Sof/Dac 4 years 6 months ago #24286

  • klhilde
  • klhilde's Avatar
  • Offline
  • Elite Member
  • Posts: 253
  • Thank you received: 498
  • Karma: 6
Phase III trials show 99% SVR in types 1,2,4,5,6 after 12 week treatment, and 95% for type 3 after 8 week treatment. These trials used no NS5B inhibitor. Imagine it in combo with Sofosbuvir.

finance.yahoo.com/news/abbvie-abbv-prese...-data-152503586.html

Why they keep doing 8 week trials, especially for type 3 patients, baffles me. These drugs' exorbitant prices do not come from their manufacturing cost ... therefore, drop the price by 1/3 and sell 50% more product, get the same revenue and stop screwing around with people's lives.

AbbVie on ENDURANCE-3:
news.abbvie.com/news/eight-weeks-treatme...onic-hepatitis-c.htm

AbbVie on EXPEDITION-1:
news.abbvie.com/news/abbvies-investigati...nsated-cirrhosis.htm
Last Edit: 4 years 6 months ago by klhilde.
The administrator has disabled public write access.
The following user(s) said Thank You: coral
Time to create page: 0.071 seconds

Copyright © 2015-2020 FixHepC

Back to Top